Here, we have explored the hypothesis that failure of systemic chemotherapy could be attributed to a cholesterol rich tumor environment, where aberrant activation of the scOHC:LXR:Pgp signaling axis is co-opted to confer resistance to common chemotherapy drugs. The gene discussed is PGP; the disease is neoplasm.